<?xml version="1.0" encoding="UTF-8"?>
<results title="tropicalVirus">
 <result pre="Neurology1664-2295Frontiers Media S.A. pmcid: 6465516 doi: 10.3389/fneur.2019.00319 : Neurology: Review" exact="Zika" post="Virus Potentiates the Development of Neurological Defects and Microcephaly:"/>
 <result pre="comply with these terms. Abstract Since the beginning of the" exact="Zika" post="Virus (ZIKV) epidemic, thousands of cases presenting ZIKV symptoms"/>
 <result pre="of the Zika Virus (ZIKV) epidemic, thousands of cases presenting" exact="ZIKV" post="symptoms were recorded in Brazil, Colombia (South America), French"/>
 <result pre="other countries of Central and North America. In Brazil, during" exact="ZIKV" post="outbreak thousands of microcephaly cases occurred that caused a"/>
 <result pre="among scientists and researchers to confirm the suspected association between" exact="ZIKV" post="infection and microcephaly. In this review article we comprehensively"/>
 <result pre="this review article we comprehensively studied scientific literature to analyze" exact="ZIKV" post="relationship with microcephaly, recent experimental studies, challenge and shortcomings"/>
 <result pre="status of this association. The evidences supporting the association of" exact="ZIKV" post="infection with congenital microcephaly and fetal brain tissue damage"/>
 <result pre="mechanism and experimental studies. However, serious attention is required toward" exact="ZIKV" post="vaccine development, standardization of anthropometric techniques, centralization of data,"/>
 <result pre="data, and advance research to clearly understand the mechanism of" exact="ZIKV" post="infection causing microcephaly. Zika virus emerging infection microcephaly neurological"/>
 <result pre="to clearly understand the mechanism of ZIKV infection causing microcephaly." exact="Zika" post="virus emerging infection microcephaly neurological disorders public health fig-count:"/>
 <result pre="public health fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction The" exact="Zika" post="virus (ZIKV) is a mosquito-borne, single-stranded RNA, flavivirus that"/>
 <result pre="harsh conditions and temperature as high as 40°C (1, 2)." exact="ZIKV" post="natural transmission cycle mainly involves the genus Aedes mosquito"/>
 <result pre="contact (6) (Figure 1). The most common laboratory tests for" exact="Zika" post="virus confirmation constitute both RNA and antibody detection in"/>
 <result pre="confounding factors and ambiguities in previously reported data (9), the" exact="ZIKV" post="association with microcephaly was considered ambiguous. However, the World"/>
 <result pre="cohort and case-control studies claimed a strong scientific consensus that" exact="ZIKV" post="infection is cause of microcephaly, Guillain-Barré syndrome (GBS) and"/>
 <result pre="A recent Lancet report has also presented genuine facts that" exact="ZIKV" post="infection is the cause of congenital microcephaly (11). Figure"/>
 <result pre="infection is the cause of congenital microcephaly (11). Figure 1" exact="Zika" post="virus infection is transmitted to human population via mosquito"/>
 <result pre="and from mother to fetus. The geographically widespread epidemic of" exact="ZIKV" post="emerged as a profoundly important public health concern when"/>
 <result pre="brain injury, craniosynostosis, drugs, hypertensive disorders, intrauterine infections caused by" exact="West Nile" post="virus (WNV), and Chikungunya virus (CHIKV) (9), and other"/>
 <result pre="disorders, intrauterine infections caused by West Nile virus (WNV), and" exact="Chikungunya" post="virus (CHIKV) (9), and other prenatal viral infections e.g.,"/>
 <result pre="16). The number of suspected congenital microcephaly cases associated with" exact="ZIKV" post="in Brazil had increased to 2975 by January 2016,"/>
 <result pre="to 2975 by January 2016, and new cases of adult" exact="ZIKV" post="infection were being reported from countries throughout the Caribbean"/>
 <result pre="and South America (12). The World Health Organization (WHO) declared" exact="ZIKV" post="as Public Health Emergency of International Concern (PHEIC) on"/>
 <result pre="recorded congenital microcephaly cases soared up in the geographically widespread" exact="ZIKV" post="epidemic regions (7, 16, 17), causing a state of"/>
 <result pre="The purpose of this review article is to comprehend if" exact="ZIKV" post="can potentially cause microcephaly. For this purpose, we comprehensively"/>
 <result pre="to discuss about the widespread epidemic of ZIKV, pathology of" exact="ZIKV" post="related microcephaly, recent in vitro and in vivo experimental"/>
 <result pre="and in vivo experimental studies to understand the mechanism of" exact="ZIKV" post="infection, ambiguities in previously published data and ZIKV future"/>
 <result pre="mechanism of ZIKV infection, ambiguities in previously published data and" exact="ZIKV" post="future implications, its control strategies and hints of advance"/>
 <result pre="research to affirm this probationary link. ZIKA Virus Epidemics The" exact="ZIKV" post="was first discovered and isolated from the blood of"/>
 <result pre="from the blood of a sentinel rhesus monkey in the" exact="Zika" post="forest of Uganda, in 1947 (18). It was occasionally"/>
 <result pre="(2015) (7, 19). As per estimation, from 2007 to 2016," exact="ZIKV" post="outbreak has affected several regions of America, Africa, Southeast"/>
 <result pre="Caribbean and western pacific island (21). In the United States," exact="ZIKV" post="cases have been reported in American Samoa, US Virgin"/>
 <result pre="US Virgin Islands and Puerto Rico. In USA, the first" exact="ZIKV" post="associated congenital microcephaly case was reported in Hawaii, in"/>
 <result pre="in 2016 (21). Due to a high cross-reactivity rate of" exact="ZIKV" post="it is often misdiagnosed as DENV as happened in"/>
 <result pre="high cross-reactivity rate of ZIKV it is often misdiagnosed as" exact="DENV" post="as happened in the Yap Island. Its potential association"/>
 <result pre="French Polynesia, Brazil, America, Slovenia and Colombia (22). During the" exact="Zika" post="virus pandemic in the French Polynesia, an unexpected rise"/>
 <result pre="consulted physicians due to suspected infection (9). Among patients presenting" exact="ZIKV" post="like symptoms that visited health care units, 1.3 per"/>
 <result pre="cases were reported but no identification tests were performed as" exact="ZIKV" post="infection was not suspected (12). After the ZIKV epidemic,"/>
 <result pre="performed as ZIKV infection was not suspected (12). After the" exact="ZIKV" post="epidemic, 18 of the 27 states of Brazil reported"/>
 <result pre="ZIKV epidemic, 18 of the 27 states of Brazil reported" exact="ZIKV" post="autochthonous cases between April and November 2015. It caused"/>
 <result pre="The WHO issued an epidemiological alert about the relationship of" exact="ZIKV" post="infection with neurological syndromes and congenital microcephaly, after confirmation"/>
 <result pre="cases (16). It is estimated that in South America the" exact="ZIKV" post="epidemic has infected more than 1 million Brazilians until"/>
 <result pre="than 1 million Brazilians until 2015 (24). Clinical Manifestations of" exact="ZIKV" post="Infection Pathology studies have significantly contributed to the understanding"/>
 <result pre="the understanding of fetal/neonatal anatomic abnormalities and relationship between intrauterine" exact="ZIKV" post="infection and damage to cerebral tissue (12). Here we"/>
 <result pre="infection and damage to cerebral tissue (12). Here we discussed" exact="ZIKV" post="related microcephaly clinical manifestations to better understand the outcomes"/>
 <result pre="A retrospective review (March 2014–May 2015), was conducted to identify" exact="ZIKV" post="related brain abnormalities in French Polynesian neonates. It was"/>
 <result pre="whose blood samples were negative for virus (13), showed that" exact="ZIKV" post="can possibly cross the placental barrier (27). Cauchemez et"/>
 <result pre="(27). Cauchemez et al. calculated the risk of microcephaly during" exact="ZIKV" post="outbreak in French Polynesian outbreak (Sept, 2013, to July,"/>
 <result pre="10,000 cases (1%) of neonates and fetuses whose mothers got" exact="ZIKV" post="infection in their first trimesters had microcephaly, a prevalence"/>
 <result pre="(CT), 23 cases of microcephalic infants born to mothers showing" exact="ZIKV" post="symptoms during first or second trimesters were discussed by"/>
 <result pre="malformations were more commonly observed during the first trimester of" exact="ZIKV" post="infected mothers (12.7%) as compared to second (3.6%) and"/>
 <result pre="(99.7%) with French Polynesia, Sao Paolo, Brazil, Cambodia, and Micronesia" exact="ZIKV" post="strain (30). Similarly, cerebral examination of two microcephalic neonates"/>
 <result pre="calcifications, and necrosis. Here all reported mothers were symptomatic for" exact="ZIKV" post="infection during the first trimesters of their pregnancy and"/>
 <result pre="trimesters of their pregnancy and RT-PCR gave positive results for" exact="ZIKV" post="RNA in the brain and placental tissue samples (12)."/>
 <result pre="RNA in the brain and placental tissue samples (12). The" exact="ZIKV" post="intrauterine infection cases during third trimester, were also found"/>
 <result pre="dysmyelination and cortical hypogyration was claimed to be caused by" exact="ZIKV" post="infection as it attenuates the brain development (28). The"/>
 <result pre="and ultrasonography to get abnormal placental image (31). Amniocentesis for" exact="ZIKV" post="detection, on the contrary, is largely suggested especially in"/>
 <result pre="in case of asymptomatic fetuses despite lack of information about" exact="ZIKV" post="predictive positive value and amniotic fluid molecular detection (31)."/>
 <result pre="changes occurring to the brain, and pathophysiology of viremia in" exact="ZIKV" post="infected fetuses (27). Recently conducted animal experiments have confirmed"/>
 <result pre="infected fetuses (27). Recently conducted animal experiments have confirmed that" exact="ZIKV" post="can cause fetal demise, hydropsfetalis (32), and placental damage"/>
 <result pre="destroying central nervous system and causing severe pathological changes (27)." exact="ZIKV" post="Related in-vivo Studies Li et al. (34) used a"/>
 <result pre="Related in-vivo Studies Li et al. (34) used a contemporary" exact="ZIKV" post="strain on a mouse model to predict the ZIKV"/>
 <result pre="contemporary ZIKV strain on a mouse model to predict the" exact="ZIKV" post="relationship with microcephaly. Their findings suggested that ZIKV effectively"/>
 <result pre="predict the ZIKV relationship with microcephaly. Their findings suggested that" exact="ZIKV" post="effectively replicated in embryonic mouse brain and caused viral"/>
 <result pre="inhibited neural progenitor cells. This study supports the link between" exact="ZIKV" post="infection and microcephaly, as it closely mimicked the physiology"/>
 <result pre="on human neural Progenitor Stem cell (hNPCs) model establishes that" exact="ZIKV" post="is a neurotropic virus that directly targets developing embryonic"/>
 <result pre="a neurotropic virus that directly targets developing embryonic brain cells." exact="ZIKV" post="infection can increase cell death rate, it can further"/>
 <result pre="progression and cause attenuated hNPC growth (35). To mimic the" exact="ZIKV" post="infection Rossi et al. (36) designed interferon (IFN) alpha"/>
 <result pre="designed interferon (IFN) alpha receptors lacking mice models. They detected" exact="ZIKV" post="in brain after 3 days post-infection and caused neurologic"/>
 <result pre="diseases after 6 days post-infection, indicating the neurotropic nature of" exact="ZIKV" post="(36). ZIKV inoculation to pregnant mice resulted in infection"/>
 <result pre="6 days post-infection, indicating the neurotropic nature of ZIKV (36)." exact="ZIKV" post="inoculation to pregnant mice resulted in infection of embryonic"/>
 <result pre="lateral ventricles cavity (22, 36, 37). In a similar study," exact="ZIKV" post="injected to pregnant mice produced some animals with restricted"/>
 <result pre="viremia, when intraperitoneal inoculation of pregnant mice was performed (39)." exact="ZIKV" post="Related in-vitro Studies Researchers have successfully conducted experiments to"/>
 <result pre="in-vitro Studies Researchers have successfully conducted experiments to investigate the" exact="ZIKV" post="pathogenesis and its affinity for neurons and neural stem"/>
 <result pre="mouse, rats, and nonhuman primates have broadened our understanding about" exact="ZIKV" post="teratogenic effect on fetal brain. Dang et al. (41)"/>
 <result pre="effect on fetal brain. Dang et al. (41) investigated the" exact="ZIKV" post="and microcephaly relationship by using cerebral organoids derived human"/>
 <result pre="organoids derived human embryonic stem cells. Authors have demonstrated that" exact="ZIKV" post="is capable to disturb cell fate and restrict organoids"/>
 <result pre="al. (42) used human-induced pluripotent stem cells to investigate the" exact="ZIKV" post="infection consequences on brain development in the first trimester"/>
 <result pre="trimester with advance 3D culture models. The results illustrated that" exact="ZIKV" post="can potentially cause death of human neural stem cells"/>
 <result pre="cell volume (43). For the mechanism of human brain injury," exact="ZIKV" post="is thought to reduce the formation of brain matter"/>
 <result pre="teratogenic effect and spectrum of fetal brain malformation induced by" exact="ZIKV" post="is very broad and difficult to detect in clinical"/>
 <result pre="macaque (Macaca nemestrina) nonhuman primate model, it is demonstrated that" exact="ZIKV" post="can potentially target and destroy fetal neural stem cells,"/>
 <result pre="astrocytes and glial cell lines support the previous research that" exact="ZIKV" post="most likely infect neural stem cells, oligodendrocyte precursor cells,"/>
 <result pre="macrolide antibiotic drug azithromycin can potentially protect brain cells from" exact="ZIKV" post="infection by declining viral proliferation and its cytopathic effects"/>
 <result pre="in human astrocytes and glial cell lines (45). Challenges in" exact="ZIKV" post="Related Studies Despite the evidences supporting ZIKV association with"/>
 <result pre="(45). Challenges in ZIKV Related Studies Despite the evidences supporting" exact="ZIKV" post="association with microcephaly and neonatal/fetal brain congenital abnormalities, scientists"/>
 <result pre="can potentially cause microcephaly (31, 46). Furthermore, approximately 80% of" exact="ZIKV" post="infected patients either had no symptoms or symptoms similar"/>
 <result pre="either had no symptoms or symptoms similar to that of" exact="DENV" post="and CHIKV that were co-circulating during ZIKV outbreak in"/>
 <result pre="no symptoms or symptoms similar to that of DENV and" exact="CHIKV" post="that were co-circulating during ZIKV outbreak in Brazil. Only"/>
 <result pre="to that of DENV and CHIKV that were co-circulating during" exact="ZIKV" post="outbreak in Brazil. Only 44% of reported cases were"/>
 <result pre="normal, showing a degree of over-reporting (46). Presenting or lacking" exact="ZIKV" post="like symptoms during pregnancy does not affirm that fetus"/>
 <result pre="even if this hypothesis is considered true the ratio of" exact="ZIKV" post="related microcephaly cases are still ambiguous (1). An American"/>
 <result pre="reported case showed that pregnant women who got infected with" exact="ZIKV" post="during 2nd and 3rd trimesters still delivered healthy babies"/>
 <result pre="1st trimester of pregnancy has the highest risk of laboratory-confirmed" exact="ZIKV" post="transmission and microcephaly as compared to 2nd and 3rd"/>
 <result pre="is cautious and necessary for correctly diagnosing microcephaly ascribed to" exact="ZIKV" post="because incorrect diagnosis may exaggerate, limit or reverse this"/>
 <result pre="cohorts (39). Ruling out other viral infections to confirm the" exact="ZIKV" post="link with microcephaly is quite important (32), as during"/>
 <result pre="link with microcephaly is quite important (32), as during previous" exact="ZIKV" post="epidemic in the Pacific Islands, no severe consequences during"/>
 <result pre="Pacific Islands, no severe consequences during pregnancy were documented (47)." exact="ZIKV" post="symptomatic mothers might be misdiagnosed as other viral diseases"/>
 <result pre="be misdiagnosed as other viral diseases (11, 47), for instance," exact="West Nile" post="virus (WNV), Japanese encephalitis viruses, Dengue virus (DENV) and"/>
 <result pre="47), for instance, West Nile virus (WNV), Japanese encephalitis viruses," exact="Dengue" post="virus (DENV) and the yellow fever virus (46) that"/>
 <result pre="yellow fever virus (46) that are genetically similar to ZIKV." exact="ZIKV" post="was not a reportable neurological disease until 2015, it"/>
 <result pre="used in predicting the course of a microcephaly outbreak (46)." exact="ZIKV" post="epidemic in Cape Verde (2015–2016), probably caused by African"/>
 <result pre="causing any neurological disorder (20). Calvet et al. report on" exact="ZIKV" post="genomic RNA detection by next-generation sequencing and quantitative RT-PCR"/>
 <result pre="quantitative RT-PCR is not enough as it only confirms that" exact="ZIKV" post="is a cause of congenital infection (50), while no"/>
 <result pre="infection (50), while no recombination events were indicated in the" exact="ZIKV" post="sequenced genome, as genetic mutations for phenotypic changes has"/>
 <result pre="for other closely related flaviviruses (1). Since the exposure of" exact="ZIKV" post="and its confirmation as a potential cause of microcephaly,"/>
 <result pre="first diagnosed, and maternal clinical symptoms appeared. In Brazil, the" exact="ZIKV" post="epidemic could predict profound increase in the number of"/>
 <result pre="5–10 months later. During this time maternal laboratory tests for" exact="ZIKV" post="confirmation could be done in order to exclude any"/>
 <result pre="Americas (39). Brasil et al. claimed a positive association of" exact="ZIKV" post="with microcephaly, i.e., 4/42 cases among the exposure group"/>
 <result pre="the exposure group vs. 0/16 among the non-exposure group, without" exact="ZIKV" post="laboratory confirmation and laboratory exclusion tests (31), for instance,"/>
 <result pre="(39). Moreover, it is highly important to reexamine specimens from" exact="DENV" post="epidemics and use of virus isolations or RT-PCR for"/>
 <result pre="use of virus isolations or RT-PCR for laboratory diagnosis of" exact="DENV" post="infections as an essential component of laboratory testing algorithms"/>
 <result pre="as an essential component of laboratory testing algorithms (51). If" exact="ZIKV" post="is encountered as a first flavivirus the chances of"/>
 <result pre="chances of cross-reactivity decreases; the result will be opposite if" exact="ZIKV" post="causes a secondary flavivirus infection, because serological test results"/>
 <result pre="will be positive for DENV. If a population infected with" exact="ZIKV" post="has a background immunity for DENV or any other"/>
 <result pre="a population infected with ZIKV has a background immunity for" exact="DENV" post="or any other flavivirus, DENV cross-reactivity IgM assay may"/>
 <result pre="has a background immunity for DENV or any other flavivirus," exact="DENV" post="cross-reactivity IgM assay may lead to false results and"/>
 <result pre="assay may lead to false results and misdiagnosed cases of" exact="ZIKV" post="(51). Current and Future Implications of ZIKV Above all,"/>
 <result pre="misdiagnosed cases of ZIKV (51). Current and Future Implications of" exact="ZIKV" post="Above all, some important answers need to be explored"/>
 <result pre="need to be explored in order to understand the emerging" exact="Zika" post="virus (ZIKV), which remained obscure until the recent epidemic"/>
 <result pre="epidemics in the Americas. Clinical isolates collected from the recent" exact="ZIKV" post="epidemic in the Americas were hyper infectious in mosquitoes"/>
 <result pre="NS1 antigenaemia. Higher NS1 antigenaemia expression in infected hosts promotes" exact="ZIKV" post="infectivity and prevalence in mosquitoes, which could have facilitated"/>
 <result pre="prevalence in mosquitoes, which could have facilitated transmission during recent" exact="ZIKV" post="epidemics (52). Similarly, a single amino acid substitution at"/>
 <result pre="serine to asparagine (S139N) in the viral polyprotein significantly increased" exact="ZIKV" post="infectivity in both mouse and human neural progenitor cells"/>
 <result pre="its subsequent propagation to the Americas. The functional adaption of" exact="ZIKV" post="has made it more infectious to human NPCs, by"/>
 <result pre="NPCs, by contributing to the increased microcephaly rate in recent" exact="ZIKV" post="epidemics (53). Is it possible that genetic alterations of"/>
 <result pre="crucial to explore the full spectrum of abnormalities caused by" exact="ZIKV" post="and solid reason of neurotropism. Although evidences are supporting"/>
 <result pre="ZIKV and solid reason of neurotropism. Although evidences are supporting" exact="ZIKV" post="relationship with microcephaly and other brain injuries, yet information"/>
 <result pre="aforementioned questions to address and understand unpredictable and rapidly growing" exact="ZIKV" post="infection. It requires serious attention toward advance research, vaccine"/>
 <result pre="public and private sectors to look for innovative ways of" exact="ZIKV" post="treatment and prevention. It is essential to explore the"/>
 <result pre="and prevention. It is essential to explore the association of" exact="ZIKV" post="infection and microcephaly, especially keeping in view the 80%"/>
 <result pre="the 80% asymptomatic cases of ZIKV. Maternal clinical symptoms of" exact="ZIKV" post="can validate the diagnosis, but fetal and maternal laboratory"/>
 <result pre="Advance studies should be done to evaluate the persistence of" exact="ZIKV" post="in asymptomatic men and prolonged genital shedding (54, 55),"/>
 <result pre="prolonged genital shedding (54, 55), that may have implications for" exact="ZIKV" post="genomic RNA detection (56). In pregnant women (symptomatic or"/>
 <result pre="be eliminated (57). At present no commercial test to diagnose" exact="Zika" post="virus infection. The reverse transcription polymerase chain reaction (RT-PCR)"/>
 <result pre="reverse transcription polymerase chain reaction (RT-PCR) is performed to detect" exact="ZIKV" post="RNA in the laboratory. Antiviral immunoglobulin M (IgM) antibodies"/>
 <result pre="RNA in the laboratory. Antiviral immunoglobulin M (IgM) antibodies of" exact="ZIKV" post="that appears at the end of the first week"/>
 <result pre="or IgM enzyme linked immunosorbent assay (ELISA). Cross reaction of" exact="ZIKV" post="with other Flaviviruses can be eliminated by using PRNT"/>
 <result pre="complicated epidemiological context of the concurrent circulating CHIKV, DENV, and" exact="ZIKV" post="co-infections cannot be ignored. In French Polynesia, ZIKV infection"/>
 <result pre="DENV, and ZIKV co-infections cannot be ignored. In French Polynesia," exact="ZIKV" post="infection was associated with autoimmune and neurological complications in"/>
 <result pre="with autoimmune and neurological complications in the presence of co-circulating" exact="DENV" post="(19). Further studies, genuine laboratory and clinical differential diagnostic"/>
 <result pre="incidence of severe cases (5, 19, 48). The number of" exact="ZIKV" post="related publications, guidelines, clinical cases, recommendations and circulating data"/>
 <result pre="neurological malformations risks, especially in the regions where existence of" exact="Zika" post="virus, its vectors or local transmission is suspected (20)."/>
 <result pre="vectors or local transmission is suspected (20). Adequate counseling of" exact="ZIKV" post="infected pregnant women and those preparing for pregnancy are"/>
 <result pre="or delay their pregnancies (59). Control and prevention strategies for" exact="ZIKV" post="infection should also include increased use of insect repellent"/>
 <result pre="transmission through experimental studies (9, 40). The virological study of" exact="CHIKV" post="can shed light on the isolated strains of ZIKV"/>
 <result pre="of CHIKV can shed light on the isolated strains of" exact="ZIKV" post="from Brazil, as the global epidemic and distribution of"/>
 <result pre="similar. Phylogenetic analysis has shown that the Brazilian strains of" exact="ZIKV" post="have evolved in a mixed way. A study suggested"/>
 <result pre="presented 99% resemblance with French Polynesian strain in 2013. Brazilian" exact="Zika" post="virus strains coming from Asian lineage had alteration in"/>
 <result pre="Despite the tremendous novel work is now underway to develop" exact="ZIKV" post="vaccines, the important challenges still remain for the preclinical"/>
 <result pre="JEV, and DENV) (62), and use of currently available preclinical" exact="ZIKV" post="vaccine data can pave road to develop effective ZIKV"/>
 <result pre="preclinical ZIKV vaccine data can pave road to develop effective" exact="ZIKV" post="vaccine. ZIKV clinical vaccines development is efficient, focused and"/>
 <result pre="vaccine data can pave road to develop effective ZIKV vaccine." exact="ZIKV" post="clinical vaccines development is efficient, focused and uniquely collaborative,"/>
 <result pre="clinical trials have been initiated within the first year of" exact="ZIKV" post="epidemic (63). Recombinant DNA technology that plays an important"/>
 <result pre="kits, and therapeutics (64) should be considered to clinically develop" exact="ZIKV" post="vaccine. Perhaps this technology can help to design a"/>
 <result pre="to design a targeted antiviral vaccine, and thoroughly explain the" exact="ZIKV" post="molecular interaction with the hosts (58). Specially, DNA and"/>
 <result pre="and purified inactivated virus (PIV) vaccines are more attractive for" exact="ZIKV" post="infection by keeping in view the theoretical safety benefit"/>
 <result pre="supposed to play a pivotal role in vaccine development against" exact="ZIKV" post="infection in future (63). Nanotechnology and Zika Virus: Treatment"/>
 <result pre="vaccine development against ZIKV infection in future (63). Nanotechnology and" exact="Zika" post="Virus: Treatment and Diagnosis Nanotechnology is used for the"/>
 <result pre="Treatment and Diagnosis Nanotechnology is used for the diagnosis of" exact="Zika" post="virus (ZIKV) and dengue virus (DENV) infections; multiplexed assay"/>
 <result pre="(IgA and IgG) are more specific against NS1 antigen of" exact="ZIKV" post="infection in comparison to IgM cross reactivity method (65)."/>
 <result pre="drug or a vaccine in market that is effective against" exact="ZIKV" post="infection. However, one pharmaceutical company demonstrated clinical trials with"/>
 <result pre="(HPV); and is expected to show some antiviral activity against" exact="ZIKV" post="in trials (67, 68). Different antiviral nano-medicines have different"/>
 <result pre="and check the effectiveness of the similar antiviral nanomedicines against" exact="ZIKV" post="in near future. For example, inactivated virosomal (liposome) and"/>
 <result pre="which may show positive outcomes to treat ZIKV. Conclusions Apart" exact="West Nile" post="virus (78), thousands of congenital microcephaly cases, fetal brain"/>
 <result pre="brain tissue damage and neurological syndromes have been associated with" exact="ZIKV" post="infection. Unfortunately, the epidemics of this mosquito born, and"/>
 <result pre="standardized diagnostic test facilities, the incidence in the geographically widespread" exact="ZIKV" post="epidemic regions is higher. Animals studies showed that ZIKV"/>
 <result pre="widespread ZIKV epidemic regions is higher. Animals studies showed that" exact="ZIKV" post="is a neurotropic virus. It directly targets the developing"/>
 <result pre="apoptosis, cell-cycle arrest, and dysregulate hNPCs. During pregnancy in mice," exact="ZIKV" post="inoculation resulted in stunted heads, restricted intrauterine growth, and"/>
 <result pre="studies are needed toward advance research and vaccine development for" exact="ZIKV" post="treatment and prevention. Author Contributions RS conceived and wrote"/>
 <result pre="of Henan Province of China for MX. References References MussoDGublerDJ." exact="Zika" post="virus. Clin Microbiol Rev. (2016) 29:487–524. 10.1128/CMR.00072-1527029595 SaizJ-CVázquez-Calvo�?BlázquezABMerino-RamosTEscribano-RomeroEMartín-AcebesMAZika virus:"/>
 <result pre="newcomer. Front Microbiol. (2016) 7:49610.3389/fmicb.2016.0049627148186 FayeOFreireCCMIamarinoAFayeOde OliveiraJVCDialloMet al.Molecular evolution of" exact="Zika" post="virus during its emergence in the 20th century. PLoS"/>
 <result pre="(2014) 8:e263610.1371/journal.pntd.000263624421913 D'OrtenzioEMatheronSde LamballerieXHubertBPiorkowskiGMaquartMet al.. Evidence of sexual transmission of" exact="Zika" post="virus. N Engl J Med. (2016) 374:2195–8. 10.1056/NEJMc160444927074370 MussoDNhanT-XEmergence"/>
 <result pre="virus. N Engl J Med. (2016) 374:2195–8. 10.1056/NEJMc160444927074370 MussoDNhanT-XEmergence of" exact="Zika" post="virus. Clin Microbiol Open Access. (2015). 4:1–4. 10.4172/2327-5073.1000222 RabaanAABazziAMAl-AhmedSHAl-GhaithMHAl-TawfiqJA."/>
 <result pre="Clin Microbiol Open Access. (2015). 4:1–4. 10.4172/2327-5073.1000222 RabaanAABazziAMAl-AhmedSHAl-GhaithMHAl-TawfiqJA. Overview of" exact="Zika" post="infection, epidemiology, transmission and control measures. J Infect Public"/>
 <result pre="10.1016/j.jiph.2016.05.00727283926 deAraújo TVBRodriguesLCde Alencar XimenesRAde Barros Miranda-FilhoDMontarroyosURde MeloAPLet al.Association between" exact="Zika" post="virus infection and microcephaly in Brazil, January to May,"/>
 <result pre="case-control study. Lancet Infect Dis. (2016) 16:1356–63. 10.1016/S1473-3099(16)30318-827641777 OnoratiMLiZLiuFSousaAMMNakagawaNLiMet al.." exact="Zika" post="virus disrupts phospho-TBK1 localization and mitosis in human neuroepithelial"/>
 <result pre="glia. Cell Rep. (2016) 16:2576–92. 10.1016/j.celrep.2016.08.03827568284 CauchemezSBesnardMBompardPDubTGuillemette-ArturPEyrolle-GuignotDet al.. Association between" exact="Zika" post="virus and microcephaly in French Polynesia, 2013–15: a retrospective"/>
 <result pre="OrganizationWHZika Virus, Microcephaly and Guillain-Barré Syndrome Situation Report. (2016) VenturaCVMaiaMBravo-FilhoVGóisALBelfortR." exact="Zika" post="virus in Brazil and macular atrophy in a child"/>
 <result pre="child with microcephaly. Lancet. (2016) 387:228. 10.1016/S0140-6736(16)00006-426775125 Paz-BaileyGRosenbergESDoyleKMunoz-JordanJSantiagoGAKleinLet al.Persistence of" exact="Zika" post="virus in body fluids—preliminary report. N Engl J Med."/>
 <result pre="J Med. (2017) 379:1234–43. 10.1056/NEJMoa161310828195756 Oliveira MeloASMalingerGXimenesRSzejnfeldPOAlves SampaioSBispo de FilippisAM." exact="Zika" post="virus intrauterine infection causes fetal brain abnormality and microcephaly:"/>
 <result pre="the Child Neurology Society. Neurology. (2009) 73:887–97. 10.1212/WNL.0b013e3181b783f719752457 DriggersRWHoC-YKorhonenEMKuivanenSJääskeläinenAJSmuraTet al.." exact="Zika" post="virus infection with prolonged maternal viremia and fetal brain"/>
 <result pre="do not know. Pathog Glob Health. (2016) 110:262–8. 10.1080/20477724.2016.123480427690200 DickGWA." exact="Zika" post="virus (II). Pathogenicity and physical properties. Trans R Soc"/>
 <result pre="(1952) 46:521–34. 10.1016/0035-9203(52)90043-612995441 ZanlucaCMeloVCMosimannALSantosGISantosCNLuzK. First report of autochthonous transmission of" exact="Zika" post="virus in Brazil. Mem Inst Oswaldo Cruz. (2015) 110:569–72."/>
 <result pre="Brazil. Mem Inst Oswaldo Cruz. (2015) 110:569–72. 10.1590/0074-0276015019226061233 BroutetNKrauerFRiesenMKhalakdinaAAlmironMAldighieriSet al.." exact="Zika" post="virus as a cause of neurologic disorders. N Engl"/>
 <result pre="10.4103/jpgm.JPGM_80_1728695873 WangLValderramosSGWuAOuyangSLiCBrasilPet al.. From mosquitos to humans: genetic evolution of" exact="Zika" post="virus. Cell Host Microbe. (2016) 19:561–5. 10.1016/j.chom.2016.04.00627091703 RodriguesLC. Microcephaly"/>
 <result pre="virus. Cell Host Microbe. (2016) 19:561–5. 10.1016/j.chom.2016.04.00627091703 RodriguesLC. Microcephaly and" exact="Zika" post="virus infection. Lancet. (2016) 387:2070–2. 10.1016/S0140-6736(16)00742-X26993880 WeistKHögbergLD. ECDC publishes"/>
 <result pre="10.2807/1560-7917.ES.2016.21.46.3039927918266 SchwartzDA. Autopsy and postmortem studies are concordant: pathology of" exact="Zika" post="virus infection is neurotropic in fetuses and infants with"/>
 <result pre="transplacental transmission. Arch Pathol Lab Med. (2016) 141:68–72. 10.5858/arpa.2016-0343-OA27557413 AlvaradoMGSchwartzDA." exact="Zika" post="virus infection in pregnancy, microcephaly, and maternal and fetal"/>
 <result pre="Arch Pathol Lab Med. (2016) 141:26–32. 10.5858/arpa.2016-0382-RA27636525 AliotaMTCaineEAWalkerECLarkinKECamachoEOsorioJECharacterization of lethal" exact="Zika" post="virus infection in AG129 mice. PLoS Negl Trop Dis."/>
 <result pre="der LindenAPenaLJet al.. Computed tomographic findings in microcephaly associated with" exact="Zika" post="virus. N Engl J Med. (2016) 374:2193–5. 10.1056/NEJMc160361727050112 HoenBSchaubBFunkALArdillonVBoullardMCabiéAet"/>
 <result pre="J Med. (2016) 374:2193–5. 10.1056/NEJMc160361727050112 HoenBSchaubBFunkALArdillonVBoullardMCabiéAet al.. Pregnancy outcomes after" exact="ZIKV" post="infection in French territories in the Americas. N Engl"/>
 <result pre="Americas. N Engl J Med. (2018) 378:985–94. 10.1056/NEJMoa170948129539287 MlakarJKorvaMTulNPopovićMPoljšak-PrijateljMMrazJet al.." exact="Zika" post="virus associated with microcephaly. N Engl J Med. (2016)"/>
 <result pre="N Engl J Med. (2016) 374:951–8. 10.1056/NEJMoa160065126862926 BrasilPPereiraJPJr.MoreiraMERibeiro NogueiraRMDamascenoLWakimotoMet al.." exact="Zika" post="virus infection in pregnant women in Rio de Janeiro."/>
 <result pre="N Engl J Med. (2016) 375:2321–2334. 10.1056/NEJMoa160241226943629 SarnoMSacramentoGAKhouriRdoRosário MSCostaFArchanjoGet al.." exact="Zika" post="virus infection and stillbirths: a case of hydrops fetalis,"/>
 <result pre="demise. PLoS Negl Trop Dis. (2016) 10:e0004517. 10.1371/journal.pntd.000451726914330 MinerJJCaoBGoveroJSmithAMFernandezECabreraOHet al.." exact="Zika" post="virus infection during pregnancy in mice causes placental damage"/>
 <result pre="in mice. Cell Stem Cell. (2016) 19:120–6. 10.1016/j.stem.2016.04.01727179424 TangHHammackCOgdenSCWenZQianXLiYet al.." exact="Zika" post="virus infects human cortical neural progenitors and attenuates their"/>
 <result pre="RossiSLTeshRBAzarSRMuruatoAEHanleyKAAugusteAJet al.. Characterization of a novel murine model to study" exact="Zika" post="virus. Am J Trop Med Hyg. (2016) 94:1362–9. 10.4269/ajtmh.16-011127022155"/>
 <result pre="virus. Am J Trop Med Hyg. (2016) 94:1362–9. 10.4269/ajtmh.16-011127022155 WangJ-NLingF." exact="Zika" post="virus infection and microcephaly: evidence for a causal link."/>
 <result pre="Res Public Health. (2016) 13:1031. 10.3390/ijerph1310103127775637 CugolaFRFernandesIRRussoFBFreitasBCDiasJLMGuimarãesKPet al.. The Brazilian" exact="Zika" post="virus strain causes birth defects in experimental models. Nature."/>
 <result pre="models. Nature. (2016) 534:267–71. 10.1038/nature1829627279226 WuK-YZuoG-LLiX-FYeQDengY-QHuangX-Yet al.. Vertical transmission of" exact="Zika" post="virus targeting the radial glial cells affects cortex development"/>
 <result pre="mice. Cell Res. (2016) 26:645–54. 10.1038/cr.2016.5827174054 Adams WaldorfKMNelsonBRStencel-BaerenwaldJEStudholmeCKapurRPArmisteadBet al.. Congenital" exact="Zika" post="virus infection as a silent pathology with loss of"/>
 <result pre="the fetal brain. Nat Med. (2018) 24:368–74. 10.1038/nm.448529400709 DangJTiwariSKLichinchiGQinYPatilVSEroshkinAMet al.." exact="Zika" post="virus depletes neural progenitors in human cerebral organoids through"/>
 <result pre="Cell Stem Cell. (2016) 19:258–65. 10.1016/j.stem.2016.04.01427162029 GarcezPPLoiolaECMadeiro da CostaRHigaLMTrindadePDelvecchioRet al.." exact="Zika" post="virus impairs growth in human neurospheres and brain organoids."/>
 <result pre="352:816–8. 10.1126/science.aaf611627064148 QianXNguyenHNSongMMHadionoCOgdenSCHammackCet al.. Brain-region-specific organoids using mini-bioreactors for modeling" exact="ZIKV" post="exposure. Cell. (2016) 165:1238–54. 10.1016/j.cell.2016.04.03227118425 TetroJAZika and microcephaly: causation,"/>
 <result pre="or coincidence. Microbes Infect. (2016) 18:167–8. 10.1016/j.micinf.2015.12.01026774330 RetallackHDi LulloEAriasCKnoppKALaurieMTSandoval-EspinosaCet al.." exact="Zika" post="virus cell tropism in the developing human brain and"/>
 <result pre="USA. (2016) 113:14408–14413. 10.1073/pnas.161802911327911847 TeixeiraMGCosta MdaCde OliveiraWKNunesMLRodriguesLC. The epidemic of" exact="Zika" post="virus–related microcephaly in Brazil: detection, control, etiology, and future"/>
 <result pre="future scenarios. Am J Public Health. (2016) 106:601–5. 10.2105/AJPH.2016.30311326959259 RasmussenSAJamiesonDJHoneinMAPetersenLR." exact="Zika" post="virus and birth defects—reviewing the evidence for causality. N"/>
 <result pre="N Engl J Med. (2016) 374:1981–7. 10.1056/NEJMsr160433827074377 MussoDRocheCNhanT-XRobinETeissierACao-LormeauV-M. Detection of" exact="Zika" post="virus in saliva. J Clin Virol. (2015) 68:53–5. 10.1016/j.jcv.2015.04.02126071336"/>
 <result pre="J Clin Virol. (2015) 68:53–5. 10.1016/j.jcv.2015.04.02126071336 Schuler-FacciniL. Possible association between" exact="Zika" post="virus infection and microcephaly—Brazil, 2015. MMWR Morb Mortal Wkly"/>
 <result pre="(2016) 65:59–62. 10.15585/mmwr.mm6503e226820244 CalvetGAguiarRSMeloASOSampaioSADe FilippisIFabriAet al.. Detection and sequencing of" exact="Zika" post="virus from amniotic fluid of fetuses with microcephaly in"/>
 <result pre="(2016) 16:653–60. 10.1016/S1473-3099(16)00095-526897108 LanciottiRSKosoyOLLavenJJVelezJOLambertAJJohnsonAJet al.. Genetic and serologic properties of" exact="Zika" post="virus associated with an epidemic, Yap State, Micronesia, 2007."/>
 <result pre="Infect Dis. (2008) 14:1232–9. 10.3201/eid1408.08028718680646 LiuYLiuJDuSShanCNieKZhangRet al.. Evolutionary enhancement of" exact="Zika" post="virus infectivity in Aedes aegypti mosquitoes. Nature. (2017) 545:482–6."/>
 <result pre="YuanLHuangX-YLiuZ-YZhangFZhuX-LYuJ-Yet al.. A single mutation in the prM protein of" exact="Zika" post="virus contributes to fetal microcephaly. Science. (2017) 358:933–6. 10.1126/science.aam712028971967"/>
 <result pre="fetal microcephaly. Science. (2017) 358:933–6. 10.1126/science.aam712028971967 NicastriECastillettiCLiuzziGIannettaMCapobianchiMRIppolitoG. Persistent detection of" exact="Zika" post="virus RNA in semen for six months after symptom"/>
 <result pre="Haiti to Italy, February 2016. Eurosurveillance. (2016) 21:1–4. 10.2807/1560-7917.ES.2016.21.32.3031427541989 NicastriECastillettiCBalestraPGalganiSIppolitoG." exact="Zika" post="virus infection in the central nervous system and female"/>
 <result pre="during pregnancy on fetal development. Reproduction. (2013) 146:R151–62. 10.1530/REP-13-023223884862 HajraABandyopadhyayDHajraSK." exact="Zika" post="virus: a global threat to humanity: a comprehensive review"/>
 <result pre="N Am J Med Sci. (2016) 8:123–8. 10.4103/1947-2714.17911227114968 HamelRLiégeoisFWichitSPomponJDiopFTalignaniLet al.." exact="Zika" post="virus: epidemiology, clinical features and host-virus interactions. Microbes Infect."/>
 <result pre="PetersenLRJamiesonDJPowersAMHoneinMAZika virus. N Engl J Med. (2016) 374:1552–63. 10.1056/NEJMra160211327028561 HayesEB." exact="Zika" post="virus outside Africa. Emerg Infect Dis. (2009) 15:1347–50. 10.3201/eid1509.09044219788800"/>
 <result pre="outside Africa. Emerg Infect Dis. (2009) 15:1347–50. 10.3201/eid1509.09044219788800 Cao-LormeauV-MRocheCTeissierARobinEBerryA-LMalletH-Pet al.." exact="Zika" post="virus, French polynesia, South pacific, 2013. Emerg Infect Dis."/>
 <result pre="vaccination. J Virol. (2014) 88:13845–57. 10.1128/JVI.02086-1425253341 BarouchDHThomasSJMichaelNL. Prospects for a" exact="Zika" post="virus vaccine. Immunity. (2017) 46:176–82. 10.1016/j.immuni.2017.02.00528228277 KhanSUllahMWSiddiqueRNabiGMananSYousafMet al.. Role"/>
 <result pre="patient: successful recovery. Ital J Pediatr. (2018) 44:140. 10.1186/s13052-018-0574-x30458831 Abbreviations" exact="ZIKV" post="Zika Virus HC Head Circumference SD Standard Deviation DENV"/>
 <result pre="successful recovery. Ital J Pediatr. (2018) 44:140. 10.1186/s13052-018-0574-x30458831 Abbreviations ZIKV" exact="Zika" post="Virus HC Head Circumference SD Standard Deviation DENV Dengue"/>
 <result pre="Abbreviations ZIKV Zika Virus HC Head Circumference SD Standard Deviation" exact="DENV" post="Dengue Virus CHIKV Chikungunya Virus WNV West Nile Virus"/>
 <result pre="ZIKV Zika Virus HC Head Circumference SD Standard Deviation DENV" exact="Dengue" post="Virus CHIKV Chikungunya Virus WNV West Nile Virus YFV"/>
 <result pre="Virus HC Head Circumference SD Standard Deviation DENV Dengue Virus" exact="CHIKV" post="Chikungunya Virus WNV West Nile Virus YFV Yellow Fever"/>
 <result pre="HC Head Circumference SD Standard Deviation DENV Dengue Virus CHIKV" exact="Chikungunya" post="Virus WNV West Nile Virus YFV Yellow Fever Virus"/>
 <result pre="Circumference SD Standard Deviation DENV Dengue Virus CHIKV Chikungunya Virus" exact="WNV" post="West Nile Virus YFV Yellow Fever Virus purified inactivated"/>
 <result pre="SD Standard Deviation DENV Dengue Virus CHIKV Chikungunya Virus WNV" exact="West Nile" post="Virus YFV Yellow Fever Virus purified inactivated virus (PIV)"/>
 <result pre="DENV Dengue Virus CHIKV Chikungunya Virus WNV West Nile Virus" exact="YFV" post="Yellow Fever Virus purified inactivated virus (PIV) MRI Magnetic"/>
</results>
